B-cell pathology in juvenile idiopathic arthritis
- PMID: 22076178
- PMCID: PMC3199973
- DOI: 10.1155/2010/759868
B-cell pathology in juvenile idiopathic arthritis
Abstract
Juvenile Idiopathic Arthritis (JIA) is the most common cause of chronic arthritis in childhood and adolescents and encompasses a heterogeneous group of different diseases. Due to the promising results of B-cell depleting therapies in rheumatoid arthritis the role of B-cells in autoimmune diseases has to be discussed in a new context. Additionally, experiments in mouse models have shed new light on the antibody-independent role of B-cells in the development of autoimmune diseases. In this review we will discuss the importance of B-cells in the pathogenesis of JIA appraising the question for an immunological basis of B-cell targeted therapy in JIA.
References
-
- Ravelli A, Martini A. Juvenile idiopathic arthritis. The Lancet. 2007;369(9563):767–778. - PubMed
-
- Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of Juvenile idiopathic arthritis: second revision, Edmonton, 2001. Journal of Rheumatology. 2004;31(2):390–392. - PubMed
-
- McGonagle D, Aziz A, Dickie LJ, McDermott MF. An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum. Pediatric Research. 2009;65(5, part 2):38R–45R. - PubMed
LinkOut - more resources
Full Text Sources
